Cancer Research Annual Meeting 2010 EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gowans, I. D.
Right arrow Articles by Wright, E. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gowans, I. D.
Right arrow Articles by Wright, E. G.
[Cancer Research 65, 3527-3530, May 1, 2005]
© 2005 American Association for Cancer Research

Priority Reports

Genotype-Dependent Induction of Transmissible Chromosomal Instability by {gamma}-Radiation and the Benzene Metabolite Hydroquinone

I. Duncan Gowans, Sally A. Lorimore, Joanne M. McIlrath and Eric G. Wright

Division of Pathology and Neuroscience, University of Dundee Medical School, Dundee, United Kingdom

Requests for reprints: Eric G. Wright, Cancer Biology and Clinical Pathology Unit, Division of Pathology and Neurosciences, University of Dundee, Ninewells Hospital and Medical School, Dundee, DD1 9SY, United Kingdom. Phone: 44-1382-632169; Fax: 44-1382-633952; E-mail: e.g.wright{at}dundee.ac.uk.


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Although it is well established that ionizing radiation and benzene are epidemiologically linked to acute myeloid leukemia (AML), the underlying mechanisms are not understood. We have shown that {gamma}-radiation can induce a persisting genomic instability in the clonal descendants of hemopoietic stem cells manifested as a high frequency of nonclonal chromosome and chromatid aberrations. A strikingly similar instability is shown after exposure to the benzene metabolite hydroquinone. The CBA/Ca but not the C57BL/6 genotype is susceptible to the induction of instability by both ionizing radiation and hydroquinone and exposure of CBA/Ca, but not C57BL/6, mice to either agent is known to be associated with the development of AML. The results are consistent with the proposal that chromosomal instability induced by either agent may contribute to AML development by increasing the number of genetic lesions in hemopoietic cells. Genotype-dependent chromosomal instability can be induced by hydroquinone doses that are not acutely stem cell toxic and this may have important implications for current assessment of safe levels of exposure to benzene as well as for mechanistic understanding of the hemotoxic and leukemogenic effects.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
Although benzene has long been known to be hemotoxic and leukemogenic from both epidemiologic studies and laboratory models, the underlying mechanisms remain obscure (1). Benzene is not a classic chemical carcinogen as there is little evidence for the production of highly electrophilic DNA-binding metabolites in vivo (2, 3). The hemopoietic effects are mediated through the generation of reactive oxygen species by its principle metabolite hydroquinone (4, 5), but neither benzene nor the majority of its metabolites are mutagenic in the Ames test (6). However, in addition to ionizing radiation, benzene is one of the few agents known to be associated with acute myeloid leukemia (AML). Exposure of CBA strains of mice to either radiation or benzene leads to the development of AML (7); although, whereas the CBA model of radiation-induced AML has found wide acceptance as a robust model, benzene-induced AML is less well established. In contrast, C57BL/6 mice exposed to radiation or benzene, like most mouse strains, develop various lymphoid malignancies (8, 9) and the majority of benzene toxicity studies have not been conducted with CBA strains.

Cytotoxic and genetic changes are readily shown in irradiated cells but there is now a substantial body of evidence that high frequencies of chromosome aberrations and gene mutations may be shown in unirradiated cells that are the progeny of cells exposed to ionizing radiation many cell divisions previously. These delayed effects are manifestations of radiation-induced genomic instability (10–12). The induction of radiation-induced chromosomal instability in hemopoietic cells from CBA strains of mice can be shown as nonclonal chromosome and chromatid-type aberrations in the clonal progeny of hemopoietic stem cells (13), but the relationship of inducible instability and AML induction is not known. We now report that both {gamma}-irradiation and hydroquinone induce chromosomal instability in a genotype-dependent manner and that induction by hydroquinone can be by doses that are not acutely toxic to stem cells. The induction of this genotype-dependent phenotype by such disparate agents, both of which are implicated in the induction of AML together with the significant susceptibility of the CBA strain both to chromosomal instability and to AML supports the view that such instability may contribute to disease development.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
Cells and treatments. Single cell suspensions of femoral bone marrow were obtained from 8- to 16-week-old CBA/Ca or C57BL/6 mice. All procedures were carried with local Ethical Committee approval and in accordance with Home Office project license PPL 60/2841. Cells (5 x 106/mL) were incubated with 0 to 600 µmol/L hydroquinone (Sigma-Aldrich, St. Louis, MO) hydroquinone at 37°C, washed twice, resuspended, and counted. Alternatively, the same number and concentration of cells were {gamma}-irradiated at a dose rate of 0.45 Gy/min using a CIS Bio International 637 Cesium irradiator to a total dose of 4 Gy, a potentially leukemogenic dose for CBA strains of mice (7). Sham-treated controls were also obtained.

Cell assays. An in vitro clonogenic assay, operationally defined as the colony-forming units in agar (CFU-A) assay, was used to obtain clones of cells derived from members of the hemopoietic stem cell compartment as described previously (14). Cells were plated in 45-mm vented Petri dishes (Sterilin, Stone, United Kingdom) containing 2 mL modified alpha Eagles medium (Life Technologies, Gaithersburg, MD) supplemented with 25% pretested horse serum (Sera-Lab), 50 µg/mL streptomycin, 50 IU penicillin, 2 mmol/L L-glutamine, and 0.3% low melting point agarose (Life Technologies) and conditioned medium from the AF1.19T and L929 cell lines batch tested to provide maximal colony-stimulating activity. Cultures were incubated for 11 to 12 days at 37°C in a fully humidified atmosphere of 5% CO2 in air to obtain mixed lineage colonies of ≥2-mm diameter. An in vivo clonogenic assay, operationally defined as the spleen CFU (CFU-S) assay that detects the same cell type as the in vitro CFU-A assay (14), was also used to obtain clones of cells derived from members of the hemopoietic stem cell compartment. Male cells were resuspended at 2.5 x 105 cells/mL and 0.2-mL aliqouts injected into the dorsal tail vein of each of six to eight female recipients conditioned with 9-Gy {gamma}-radiation. On days 10 to 11, spleens were obtained, individual colonies dissected out, and cell suspensions obtained for cytogenetic analyses. In addition to confirming the presence of Y chromosome in scored metaphases, each colony was checked for evidence of donor origin using a PCR-based technique. A small aliquot of each colony (~50,000 cells) was added to two volumes of NSD buffer [10 mmol/L Tris-HCl (pH 8.0), 0.5 mmol/L EDTA (pH 8.0), 1% N-laurly sarcosyl], vortexed, and kept on ice for 10 minutes before proteinase K (5 µg/mL overnight at 42°C) and RNAase A treatment (100 µg/mL for 1 hour at 37°C). DNA was extracted using phenol/chloroform and was precipitated overnight at –20°C in 0.3 mol/L sodium acetate, 65% ethanol. Samples were spun at 31,000 rpm (43 000 x g) for 1 hour at 4°C, washed once with 70% ethanol and spun for a further 20 minutes at 4°C before air drying and redissolving the pellet in 10 µL TE 1/0.1 pH 8.0. PCR reactions were done on a Hybaid Omni thermal cycler in 25-µL reaction volumes using the primers YF, CCTATTGCATGGACTGCAGCTTA and YR, GACTAGACATGTCTTAACATCTG (Sigma Genosys, The Woodlands, TX) at 0.5 µmol/L using 1.25 units HotStarTaq (Qiagen, Chatsworth, CA), 1.5 mmol/L MgCl2, and 200 µmol/L deoxynucleotide triphosphate's. Following a 15-minute cycle at 95°C, 30 cycles of 1-minute segments with the following reaction conditions were done: 95°C, 60°C, and 72°C. A product of ~200 bp was visualized by UV light on a 3% agarose gel using ethidium bromide. Positive and negative controls plus blank samples were included in each run.

Cytogenetic analysis. Cells to which Colcemid had been added at final concentration of 0.02 µg/mL were incubated for one hour at 37°C. The cells were resuspended in 5 mL hypotonic potassium chloride (0.5%) for 30 minutes before adding 2 mL sodium citrate/potassium chloride and incubating for a further 8 minutes. Two to 3 mL of fixative (methanol/acetic acid, 3:1) was added and the sample inverted once. After 10 to 15 minutes, the cells were resuspended in fixative. At least two further washes in fixative were done before the cells were dropped onto precleaned glass slides. The slides were air dried and aged for 14 days before stained with Giemsa (diluted 1:4 with distilled water and filtered) for 15 to 20 minutes. Coded samples were scored for karyotypic abnormalities and at the completion of scoring, treatments were assigned to the coded data and differences between the proportions of aberrant cells at each harvesting point were analyzed by the Fisher's exact test.


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
Hemotoxicity of hydroquinone. In a preliminary study, femoral bone marrow from CBA/Ca mice was incubated with hydroquinone at concentrations of 0, 200, and 600 µmol/L and samples taken at 60, 120, and 240 minutes. Two hundred cells were examined for trypan blue exclusion in each group at each time point and those cells that took up dye were regarded as dead or dying cells. The number of such cells increased with time and dose with higher doses resulting in a more rapid cell death. Exposure to 200 µmol/L hydroquinone resulted in 70%, 40%, and 23% survival at 60, 120, and 240 minutes, respectively. Increasing the dose to 600 µmol/L decreased these survivals to 40%, 25%, and 28%, respectively. These data provide an indication of overall toxicity for total bone marrow where most of the cells are differentiating/differentiated effector cells. Thus, additional studies using functional assays of primitive multipotential clonogenic stem cells, as more relevant target cells, were undertaken. Using an in vitro clonogenic (CFU-A) assay, the fractions surviving 2-hour exposures to various hydroquinone doses were determined and shown in Fig. 1. There was no significant toxicity at 10 µmol/L but doses >200 µmol/L resulted in <30% survival (Fig. 1). Accordingly, cytogenetic studies were conducted using bone marrow exposed to 10 and 300 µmol/L hydroquinone.



View larger version (11K):
[in this window]
[in a new window]
[Download PPT slide]
  		Figure 1. Clonogenic stem cell survival after 2 hours of incubation of bone marrow with hydroquinone (HQ) assayed in triplicate using the in vitro CFU-A assay. Points, mean; bars, SE.

 
Cytogenetic analyses. Using an in vivo clonogenic (CFU-S) transplantation assay, stem cells exposed in vitro were stimulated to proliferate and differentiate in vivo for 10 to 11 days and donor-derived clones (confirmed by PCR analysis) of ~106 cells were processed for cytogenetic studies; the results are summarized in Table 1. In the in vivo colonies derived from sham-treated control CBA/Ca bone marrow, the frequency of cells with unstable aberrations (chromatid breaks, chromosome fragments and minutes) was ~3%. In colonies initiated from cell exposed to 10 or 300 µmol/L hydroquinone, the incidence of unstable aberrations was significantly increased relative to the control group (8.5%, P = 6 x 10–6 and 7.0%, P = 1. 6 x 10–3, respectively). However, there was no evidence of dose dependency as there was no significant difference between the level of instability after 10 µmol/L treatment and after 300 µmol/L treatment (8.5% and 7.0%, P = 0.2045).


View this table:
[in this window]
[in a new window]

  		Table 1. Nonclonal aberrations in stem cell-derived colonies derived from hydroquinone-exposed or {gamma}-irradiated bone marrow assayed in triplicate using the in vivo CFU-S assay

 
In colonies derived from sham-treated control C57BL/6 bone marrow, the frequency of cells with unstable aberrations was ~2%; not significantly different from CBA/Ca controls (P = 0.1361). In colonies initiated from cells exposed to 10 or 300 µmol/L hydroquinone, the incidence of unstable aberrations was not significantly increased relative to controls (3.0%, P = 0.8912 and 1.3%, P = 0.2858, respectively).

Colonies derived from {gamma}-irradiated clonogenic cells of both genotypes exhibited levels of instability greater than their respective controls (for CBA/Ca cells, 12.9% versus 3.1%, P < 1.0 x 10–7 and for C57BL/6 cells, 4.4% versus 1.9%, P = 0.0127). However, the level of instability in colonies derived from irradiated C57BL/6 clonogenic cells was significantly lower (P = 7.0 x 10–6) than in the corresponding CBA/Ca-derived colonies. Comparing the expression of unstable aberrations in colonies derived from hydroquinone-treated cells of the two genotypes, it is evident that the CBA/Ca-derived colonies exhibited a greater percentage of cells with aberrations than in the corresponding C57BL/6-derived cells. For the 10 µmol/L treatments, 8.5% of CBA/Ca and 3.0% of C57BL/6 cells (P = 1.16 x 10–3) and for the 300 mmol/L treatments, 7.0% of CBA/Ca cells and 1.3% of C57BL/6 cells (P = 4.0 x 10–6).


   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
This study has shown a high frequency of de novo chromosome aberrations in cells that were not themselves exposed to hydroquinone but in the progeny of clonogenic stem cells exposed many cell populations previously. This phenotype is directly comparable to that of radiation-induced chromosomal instability, an untargeted effect of ionizing radiation in which aberrations that are readily and expectedly observed in cells at the first division post-irradiation are unexpectedly shown as nonclonal abnormalities in the clonal descendants of irradiated cells many cell divisions after exposure (12). No clonal aberrations were recorded after hydroquinone exposure, but this is not unexpected given the relatively small number of colonies studied and it is consistent with previous observations that the frequency of induction of instability in hemopoietic cells of a susceptible genotype is considerably greater than the frequency of induction of stable clonal aberrations (10, 11). The cytogenetic results have another significant implication, in that instability induction per treated cell (i.e., per initial cell at risk) is not dose dependent. This can be seen within the context of clonogenic cell survival (Fig. 1). For example, the instability induced by a highly toxic dose of 300 µmol/L hydroquinone (10% survival) is not significantly greater than that induced by a dose of 10 µmol/L that has no significant acute toxicity (Table 1). Consequently, low-dose exposure that has relatively little acute toxicity may, nevertheless, have important long-term biological and potentially clinical consequences. However, an additional implication of this study is that the expression of instability is strongly influenced by genetic factors; the CBA/Ca genotype may be regarded as highly susceptible and the C57BL/6 genotype as relatively resistant. Interestingly, bladder epithelium obtained from these same mouse strains irradiated in vitro, reflected the range of responses shown by similarly treated samples of human urothelium (15). These laboratory studies clearly show the importance of genetic influences on the expression of the phenotype and raise the important issue of genetic predisposition in the human population.

Currently, the mechanism of induction and perpetuation of radiation-induced genomic instability is not understood but is thought to be driven by epigenetic factors that secondarily produce genetic lesions. There is evidence that the expression of the phenotype involves intercellular communication (16, 17) and a number of studies have pointed to an association between radiation-induced chromosomal instability and free radical-mediated processes (18–20). Previous studies in vivo had indicated that macrophages in the murine hematopoietic system become activated after irradiation and produce excess levels of reactive oxygen and nitrogen species and it was proposed that the production of reactive species by macrophages in the longer term after irradiation might be involved in nontargeted and delayed effects of irradiation as part of an ongoing tissue response to radiation injury (21). Previous studies have implicated increased free radical activity in bone marrow as contributing, at least in part, to the toxic and leukemogenic effects of benzene (22, 23). The bone marrow of mice treated with benzene produced 50% more hydrogen peroxide in response to the phorbol ester, 12-O-tetradecanoyl-phorbol-13-acetate than did cells from control animals (24) suggesting that phagocyte activation may contribute to hydroquinone-induced effects and that ionizing radiation and benzene may share common indirect mechanisms of microenvironmentally mediated secondary cell damage.

This study has shown that chromosomal instability can be a high-frequency delayed consequence of exposure to both ionizing radiation and hydroquinone with the same genotype dependency. Previous studies, using CBA/Ca mice have implicated genetic instability as a factor in benzene- and radiation-induced leukemia (25) and the present study clearly shows that after either exposure, the clonal descendants of stem cells are genetically unstable in susceptible CBA/Ca mice but not in resistant C57BL/6 mice. The induction of this phenotype by such disparate agents, both of which are implicated in the induction of AML, sometimes years after the exposure, and the significant susceptibility of the CBA strain to both chromsosomal instability and AML add weight to the possible biological importance of such instability in disease development. It should be noted, however, that many AMLs in humans show normal karyotypes; thus, instability is not a universal finding and this may well reflect different responses to different leukemogenic insults. In addition, low-penetrance susceptibility and resistance loci and target stem cells numbers are factors that also impinge on the relative risk for radiation-induced AML in mice (26). In this study, the nonclonal aberrations seen in the clonal progeny of stem cells have the characteristics of spontaneous damage. This implies that induced instability would lead to a greater number of "spontaneous" mutations in the progeny of hemopoietic stem cells put under proliferative stress. Thus, inducible chromosomal instability may be a permissive event in the development of AML rather than directly causative. The induction of delayed chromosomal instability by hydroquinone doses that are not acutely stem cell toxic may have important implications for current assessment of safe levels of exposure to benzene as well as for mechanistic understanding the hemotoxic and leukemogenic effects.


   Acknowledgments
 
Grant support: Leukaemia Research Fund Specialist Program grant 0214 and Leukaemia Research Fund Clinical Research Fellowship award 0022.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received 11/30/04. Revised 2/ 7/05. Accepted 2/25/05.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Snyder R. Benzene and leukemia. Crit Rev Toxicol 2002;32:155–210.[CrossRef][Medline]
  2. Creek MR, Mani C. Vogel JS, Turteltaub KW. Tissue distribution and macromolecular binding of extremely low doses of [14C]-benzene in B6C3F1 mice. Carcinogenesis 1997;18:2421–7.[Abstract/Free Full Text]
  3. Whysner J, Reddy MV, Ross PM, Mohan M, Lax EA. Genotoxicity of benzene and its metabolites. Mutat Res 2004;566:99–130.[CrossRef][Medline]
  4. Eastmond DA, Smith MT, Irons RD. An interaction of benzene metabolites reproduces the myelotoxicity observed with benzene exposure. Toxicol Appl Pharmacol 1987;91:85–95.[CrossRef][Medline]
  5. Smith MT. The mechanism of benzene-induced leukemia: a hypothesis and speculations on the causes of leukemia. Environ Health Perspect 1996;104 Suppl 6:1219–25.
  6. Dean BJ. Recent findings on the genetic toxicology of benzene, toluene, xylenes and phenols. Mutat Res 1985;154:153–81.[CrossRef][Medline]
  7. Rithidech KN, Cronkite EP, Bond VP. Advantages of the CBA mouse in leukemogenesis research. Blood Cells Mol Dis 1999;25:38–45.[CrossRef][Medline]
  8. Kaplan HS. On the natural history of the murine leukemias: presidential address. Cancer Res 1967;27:1325–40.[Free Full Text]
  9. Cronkite EP, Bullis J, Inoue T, Drew RT. Benzene inhalation produces leukemia in mice. Toxicol Appl Pharmacol 1984;75:358–61.[CrossRef][Medline]
  10. Morgan WF. Non-targeted and delayed effects of exposure to ionizing radiation. I. Radiation-induced genomic instability and bystander effects in vitro. Radiat Res 2003;159:567–80.[Medline]
  11. Lorimore SA, Coates PJ, Wright EG. Radiation-induced genomic instability and bystander effects: inter-related nontargeted effects of exposure to ionizing radiation. Oncogene 2003;22:7058–69.[CrossRef][Medline]
  12. Wright EG. Radiation-induced genomic instability in haemopoietic cells. Int J Radiat Biol 1998;74:681–7.[CrossRef][Medline]
  13. Watson GE, Pocock DA, Papworth D, Lorimore SA, Wright EG. In vivo chromosomal instability and transmissible aberrations in the progeny of haemopoietic stem cells induced by high- and low-LET radiations. Int J Radiat Biol 2001;77:409–17.[CrossRef][Medline]
  14. Lorimore SA, Pragnell IB, Eckmann L, Wright EG. Synergistic interactions allow colony formation in vitro by murine haemopoietic stem cells. Leuk Res 1990;14:481–9.[CrossRef][Medline]
  15. Mothersill CE, O'Malley KJ, Murphy DM, Seymour CB, Lorimore SA, Wright EG. Identification and characterization of three subtypes of radiation response in normal human urothelial cultures exposed to ionizing radiation. Carcinogenesis 1999;20:2273–8.[Abstract/Free Full Text]
  16. Lorimore SA, Kadhim MA, Pocock DA, et al. Chromosomal instability in the descendants of unirradiated surviving cells after {alpha}-particle irradiation. Proc Natl Acad Sci U S A 1998;95:5730–3.[Abstract/Free Full Text]
  17. Watson GE, Lorimore SA, Macdonald DA, Wright EG. Chromosomal instability in unirradiated cells induced in vivo by a bystander effect of ionizing radiation. Cancer Res 2000;60:5608–11.[Abstract/Free Full Text]
  18. Clutton SM, Townsend KM, Walker C, Ansell JD, Wright EG. Radiation-induced genomic instability and persisting oxidative stress in primary bone marrow cultures. Carcinogenesis 1996;17:1633–9.[Abstract/Free Full Text]
  19. Limoli CL, Hartmann A, Shephard L, et al. Apoptosis, reproductive failure, and oxidative stress in Chinese hamster ovary cells with compromised genomic integrity. Cancer Res 1998;58:3712–8.[Abstract/Free Full Text]
  20. Limoli CL, Kaplan MI, Giedzinski E, Morgan WF. Attenuation of radiation-induced genomic instability by free radical scavengers and cellular proliferation. Free Radic Biol Med 2001;31:10–9.[CrossRef][Medline]
  21. Lorimore SA, Coates PJ, Scobie GE, Milne G, Wright EG. Inflammatory-type responses after exposure to ionizing radiation in vivo: a mechanism for radiation-induced bystander effects? Oncogene 2001;20:7085–95.[CrossRef][Medline]
  22. Subrahmanyam VV, Ross D, Eastmond DA, Smith MT. Potential role of free radicals in benzene-induced myelotoxicity and leukemia. Free Radic Biol Med 1991;11:495–515.[CrossRef][Medline]
  23. Winn LM. Homologous recombination initiated by benzene metabolites: a potential role of oxidative stress. Toxicol Sci 2003;72:143–9.[Abstract/Free Full Text]
  24. Laskin DL, MacEachern L, Snyder R. Activation of bone marrow phagocytes following benzene treatment of mice. Environ Health Perspect 1989;82:75–9.[Medline]
  25. Rithidech K, Dunn JJ, Bond VP, Gordon CR, Cronkite EP. Characterization of genetic instability in radiation- and benzene-induced murine acute leukemia. Mutat Res 1999;428:33–9.[Medline]
  26. Boulton E, Cleary H, Papworth D, Plumb M. Susceptibility to radiation-induced leukaemia/lymphoma is genetically separable from sensitivity to radiation-induced genomic instability. Int J Radiat Biol 2001;77:21–9.[CrossRef][Medline]



This article has been cited by other articles:


Home page
 Toxicol SciHome page
X. Ren, S. Lim, M. T. Smith, and L. Zhang
Werner Syndrome Protein, WRN, Protects Cells from DNA Damage Induced by the Benzene Metabolite Hydroquinone
Toxicol. Sci., February 1, 2009; 107(2): 367 - 375.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. A. Lorimore, J. A. Chrystal, J. I. Robinson, P. J. Coates, and E. G. Wright
Chromosomal Instability in Unirradiated Hemaopoietic Cells Induced by Macrophages Exposed In vivo to Ionizing Radiation
Cancer Res., October 1, 2008; 68(19): 8122 - 8126.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
M. S. Fox and S. Klawansky
Interruption of cell transformation and cancer formation
FASEB J, November 1, 2006; 20(13): 2209 - 2213.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
M. Shen, Q. Lan, L. Zhang, S. Chanock, G. Li, R. Vermeulen, S. M. Rappaport, W. Guo, R. B. Hayes, M. Linet, et al.
Polymorphisms in genes involved in DNA double-strand break repair pathway and susceptibility to benzene-induced hematotoxicity
Carcinogenesis, October 1, 2006; 27(10): 2083 - 2089.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gowans, I. D.
Right arrow Articles by Wright, E. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gowans, I. D.
Right arrow Articles by Wright, E. G.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online